Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sutro Biopharma

Explore full profile

Develops protein therapeutics by using OCFS protein synthesis technology

South San Francisco, United StatesFounded 2003Biotech & Life Sciences
Valuation $211M Market cap · Aug/2026
Revenue $45M Latest reported FY

At a glance

Status
Listed
Founded
2003
Headquarters
South San Francisco, United States
Listing
IPO 2018
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • SV Health Investors

Series B and later10 investors entered at this stage

  • Celgene
  • Tekla Capital Management
  • Samsara BioCapital
  • Vida Ventures
  • Amgen Ventures
  • Skyline Ventures
  • Lilly Ventures
  • Citadel
  • Merck & Co.
  • Alta Partners

Talent

Book a demo to see the people
Employees mapped 209 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Sutro Biopharma employees who went on to found companies, sorted by Dealroom signal score.

InterVennEst. 2017
Lieza MarieUnited States
Signal score70
Greenlight BiosciencesEst. 2008
James SwartzUnited States
Signal score65
ActymEst. 2017
Christopher ThanosUnited States
Signal score61
eCommeraEst. 2007
Michael RossUnited Kingdom
Signal score59
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.5%
🇩🇪 Germany0.5%
2 countries shown
Web traffic by country
12K monthly visits
across markets
🇺🇸 United States52.5%
🇯🇵 Japan12.5%
🇮🇳 India11.7%
🇪🇸 Spain7.5%
🇨🇭 Switzerland4.2%
Top 5 markets shown

Patents

Estimated portfolio value
$83M

52 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sutro Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sutro Biopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles